Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Technique Designs Nucleic Acid Probes to Detect Rapidly Mutating Bacteria and Viruses

By LabMedica International staff writers
Posted on 16 Feb 2023

The COVID-19 pandemic has shown that the microbes responsible for some infections can rapidly mutate into variants which evade detection and treatment. More...

Now, researchers have developed a technique called AutoPLP that designs nucleic acid probes to help quickly, accurately and easily detect new variants of pathogens which can be hard to trace. This could help prevent infections that have the potential to spread quickly due to these dangerous variants.

Several diagnostics like the ones based on the polymerase chain reaction (PCR) detect pathogens by analyzing genetic material. Rolling circle amplification (RCA) works similarly but eliminates the need for complex temperature cycling unlike PCR. Both the approaches need nucleic acid probes with sequences that match those of the target pathogen in specific locations, although RCA utilizes highly specific “padlock probes” (PLPs). When a pathogen mutates, there is also a change in its genetic sequence, forcing researchers to keep redesigning their probes. So, researchers from the Indian Institute of Technology (IIT) Madras (Chennai, India) set out to create a tool that could automatically design these PLPs, as well as systematically take into account all the required technical parameters simultaneously to make the overall process easier and more robust.

The new tool, a computer program termed AutoPLP has been named after the PLPs it designs. The program takes the genome sequences of similar pathogens as input and runs a series of analyses and database searches, outputting a set of customized PLP sequences. Using the program, the researchers designed probes against the rabies virus and Mycobacterium tuberculosis. In the case of the rabies virus, AutoPLP targeted three genes, yielding probes with a higher and narrower range of melting temperatures as compared to those in the literature. In the case of M. tuberculosis, the team designed 13 probes that specifically targeted the two genes responsible for drug-resistant strains with the program. According to the researchers, the new tool could speed up the discovery of new pathogen variants, thus helping fight them rapidly and effectively through the use of precise molecular diagnostics.

Related Links:
IIT Madras


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.